You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic phase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metabolic Alternation and Clinicohematological Characteristic in

Not yet recruiting
  • CML, Chronic Phase
  • Tyrosine kinase inhibitor
  • (no location specified)
Nov 6, 2023

Ponatinib in CML Patients in Chronic Phase

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Therapeutic drug monitoring
  • Molecular Response
  • Cagliari, Italy
  • +4 more
Nov 3, 2023

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

    Recruiting
    • CML
    • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
    • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
      FUNDALEU
    Jun 29, 2023

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    Chronic Myeloid Leukemia Trial (Asciminib)

    Available
    • Chronic Myeloid Leukemia
    • (no location specified)
    Jan 17, 2023

    Stroke Trial in Brest (LUNA-EMG Robot)

    Not yet recruiting
    • Stroke
    • LUNA-EMG Robot
    • Brest, France
      CHU Brest
    Jun 5, 2023

    Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Jena, Germany
        University Hospital Jena
      Jan 17, 2023

      Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 11, 2022

      Stroke Trial (Adapted physical activity program, Adapted physical activity self-program)

      Not yet recruiting
      • Stroke
      • Adapted physical activity program
      • Adapted physical activity self-program
      • (no location specified)
      Sep 25, 2023

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 24, 2022

      CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

      Recruiting
      • CML, Chronic Phase
      • CML, Accelerated Phase
      • HS-10382(Part 1: Dose escalation)
      • HS-10382(Part 2: Dose expansion)
      • Wuhan, Hubei, China
        Union Hospital affiliated to Tongji Medical College of Huazhong
      Jan 12, 2023

      Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • +3 more
      • Augusta, Georgia
      • +1 more
      Jul 14, 2022

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

      Not yet recruiting
      • CML, Chronic Phase
      • Harbin, Heilongjiang, China
        Institute of Hematology and Oncology, Harbin The First Hospital
      May 5, 2022

      CML, Chronic Phase Trial in Harbin (Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg))

      Recruiting
      • CML, Chronic Phase
      • Flumatinib mesylate tablets (400mg)
      • Flumatinib mesylate tablets (600mg)
      • Harbin, Hei Longjiang, China
        Institute of Hematology and Oncology, Harbin The First Hospital
      Apr 28, 2022

      New Diagnosed Chronic Phase Chronic Myeloid Leukemia

      Recruiting
      • Validity and Safety
        • Guangzhou, Guangdong, China
          NanfangH
        Apr 9, 2022

        Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia
        • Detroit, Michigan
        • +1 more
        May 3, 2022

        Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

        Recruiting
        • Olverembatinib
        • +2 more
        • Shenzhen, Guangdong, China
          Shenzhen Second People's Hospital
        Jul 26, 2022

        Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

        Recruiting
        • Chronic Myeloid Leukemia in Chronic Phase
        • Shenzhen, Guangdong, China
          Shenzhen Second People's Hospital
        Jul 26, 2022

        Spanish Version of Two Upper Limb Assessment Scales in Chronic

        Not yet recruiting
        • Chronic Stroke
        • No intervention
        • Valencia, Spain
          University of Valencia
        May 12, 2023

        Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

        Not yet recruiting
        • Leukemia
        • +12 more
        • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
        • (no location specified)
        Mar 20, 2023

        Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Dasatinib Pill
        • Ketoconazole Pill
        • Monterrey, Nuevo Leon, Mexico
          Hospital Universitario Dr. José Eleuterio González
        Nov 25, 2022

        Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

        Recruiting
        • Myeloproliferative Neoplasm
        • +2 more
        • Online Mindfulness Meditation
        • Internet-Based Webinars
        • San Francisco, California
          University of California San Francisco
        Aug 9, 2022

        Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

        Not yet recruiting
        • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
        • (no location specified)
        Jul 11, 2022